Connect to other sites within the UBM Medica Network
Local peripheral treatments plus ipilimumab may benefit those with melanoma. Image © Australis Photography/Shutterstock.com
Lung Cancer Patients With EGFR Mutations Respond Well to TKI Therapy
Researchers from China have discovered a way to offset the brain complications of leptomeningeal metastases in patients with non-small cell lung cancer.
New Treatment Receives Orphan Drug Designation for Treating Peripheral T-Cell Lymphoma
The FDA is granting Orphan Drug Designation for chimeric antigen receptor engineered T-cells directed against the target protein CD4 (CD4CAR) for the treatment of peripheral T-cell lymphoma.
Might Computers Predict Patient Survival Better Than Pathologists?
Automated computer analysis of pathology slide images can more accurately predict lung cancer patient prognosis than can human pathologists, according to researchers at the Stanford University School of Medicine.
Nivolumab Missed Primary Endpoint in NSCLC Trial
In a phase III trial, Opdivo (nivolumab) did not meet its primary endpoint, a disappointment to researchers and patients.
Right Arm Skin Lesion Found in 47-Year-Old Man
A 47-year-old man presents with an “atrophic” lesion of the skin in the right arm. After a biopsy is performed, what is your diagnosis?
On-treatment Biomarkers Predict Immune Checkpoint Blockade Responses in Melanoma
Immune response markers from on-treatment—but not pretreatment—melanoma biopsies predict responses to immune checkpoint blockade.
Is Noncoding RNA a Culprit in Prostate Cancer?
Noncoding RNA appears to be involved in the epigenetic regulation of prostate cancer, according to findings published in Nature Genetics.
Pembrolizumab Yields Strong Long-Term Survival in Advanced Melanoma
In this video we discuss 3-year overall survival data from the KEYNOTE-001 trial, which studied the anti–PD-1 antibody pembrolizumab in patients with advanced melanoma.
ASCO 2016: Phase I Trial Results With Vorinostat in Head and Neck Cancer
In this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.
March 2016 News Recap
In case you missed it, check out our March recap featuring some of the latest in clinical trial news, a new indication for Afinitor, how genetics affect prognosis, and more.
Epidermal Growth Factor Receptor Inhibitor Cutaneous Side Effects
This slide show highlights some of the cutaneous side effects related to the use of epidermal growth factor receptor inhibitors (EGFRI).
Slide Show: Highlights From the 2015 ASCO Breast Cancer Symposium
This slide show highlights some of the presentations that took place at the 2015 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco, September 25-27, 2015.
Slide Show: Trends in Targeted Therapies and Immunotherapies
This slide show provides information on the present and future of targeted therapies and immunotherapies based on a report from the IMS Institute for Healthcare Informatics.
By clicking Accept, you agree to become a member of the UBM Medica Community.